02574nam 2200625Ia 450 991082140160332120240417004217.00-309-18569-61-281-76752-297866117675250-309-11867-0(CKB)2550000000004405(EBL)3378374(SSID)ssj0000288925(PQKBManifestationID)11220286(PQKBTitleCode)TC0000288925(PQKBWorkID)10383139(PQKB)10130252(MiAaPQ)EBC3378374(Au-PeEL)EBL3378374(CaPaEBR)ebr10237094(CaONFJC)MIL176752(OCoLC)923279005(EXLCZ)99255000000000440520080521d2008 uy 0engur|n|---|||||txtccrAntivirals for pandemic influenza guidance on developing a distribution and dispensing program /Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies1st ed.Washington, DC National Academies Pressc20081 online resource (132 p.)Description based upon print version of record.0-309-11866-2 Includes bibliographical references.""Front Matter""; ""Reviewers""; ""Contents""; ""Summary""; ""1 Introduction""; ""2 Antiviral Effectiveness, Safety, and Supply""; ""3 Ethics, Decision Making, and Communication""; ""4 Who Should Get Antivirals and Where?""; ""References""; ""Appendixes""; ""Appendix A: Summary of Lessons Learned from Other Mass Distribution Events""; ""Appendix B: State Plans""; ""Appendix C: Meeting One Agenda""; ""Appendix D: Meeting Two Agenda""; ""Appendix E: Committee Member Biographies""Antiviral agentsEffectivenessAntiviral agentsEpidemicsPreventionInfluenzaPreventionAntiviral agentsEffectiveness.Antiviral agents.EpidemicsPrevention.InfluenzaPrevention.614.518Institute of Medicine (U.S.).Board on Population Health and Public Health Practice.MiAaPQMiAaPQMiAaPQBOOK9910821401603321Antivirals for pandemic influenza3931696UNINA